跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PONVORY ponesimod 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg film-coated tablet (Treatment initiation pack) blister composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
PONVORY ponesimod 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg film-coated tablet (Treatment initiation pack) blister composite pack
Approved
STANDARD
PONVORY ponesimod 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg film-coated tablet (Treatment initiation pack) blister composite pack
Janssen-Cilag Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f009f553826b12df
Company
Janssen-Cilag Pty Ltd
Type
Standard
Approval Details
Approval Id
f009f553826b12df
Product Name
PONVORY ponesimod 2 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7 mg, 8 mg, 9 mg, 10 mg film-coated tablet (Treatment initiation pack) blister composite pack
Artg Id
370320
Artg Name
PONVORY ponesimod 2 mg + 3 mg + 4 mg + 5 mg + 6 mg + 7 mg + 8 mg + 9 mg + 10 mg film-coated tablets (Treatment initiation pack) blister composite pack
Sponsor
Janssen-Cilag Pty Ltd
Company Detail Path
/organization/janssen-cilag-pty-ltd
Artg Date
2022-03-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/789e8e4e12f978308279e4ea93eb5f30.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f009f553826b12df
Type
Standard
Back to TGA Approvals